Vaccination coverage in the EU/EEA during autumn 2023 campaigns
Nearly 20 million people aged 60 years and above received COVID-19 vaccines during the autumn/winter campaign in the EU/EEA, according to a new report from the European Centre for Disease Prevention and Control (ECDC).
The panzootic spread of highly pathogenic avian influenza H5N1 sublineage 2.3.4.4b: a critical appraisal of One Health preparedness and prevention
With the world gradually recovering from the COVID-19 pandemic, it is important to think forward when it comes to prevention of infectious disease outbreaks originating from the animal world.
|
9th Influenza Conference 2023
ESWI 2023 Conference Science Policy Interface highlights
This report summarises ESWI’s interpretation of the key messages from the individual talks within the Science Policy Interface (SPI) track of the conference
How well does a flu vaccine work? DRIVE project evaluates performance
Despite challenging conditions posed by the COVID-19 outbreak, the DRIVE project successfully tested how well various brands of flu vaccines worked across five European countries and a range of age groups.
RSV IMMUNISATION FOR INFANTS IN EUROPE: ARE OUR HEALTH SYSTEMS READY?
EHMA publishes a paper based on expert insight from across Europe, exploring the challenges and opportunities of implementing RSV immunisation programmes in different country contexts.
A Fragile State of Preparedness: 2023 Report on the State of the World's Preparedness
The Global Preparedness Monitoring Board (GPMB) 2023 Report points out that global preparedness for pandemics and other disease outbreaks remains inadequate, making four key recommendations to urgently strengthen global preparedness.
|
9th Influenza Conference 2023
The Ninth ESWI Influenza Conference: Highlights
ESWI 2023: 10 key take home messages
Guidance for Developing a Sustainable Multistakeholder Immunization Coalition
Insights from immunization coalition experts and analysis of successful immunization coalitions
Pandemic preparedness, response and recovery: Lessons learnt for global pharmacy
Investing in science and innovation is one of six key areas of development needed to prepare for future pandemics, according to a new report conducted by the International Pharmaceutical Federation (FIP).
Pandemic Preparedness. How will the international accord help respond to unforeseen shocks?
Science|Business organised a roundtable discussion with international experts -representing industry, academia, public health bodies, think tanks, government officials and research organisations- to discuss how to prepare for future pandemics.
Progress Report: Reducing the Burden of RSV across the Lifespan
The National Foundation for Infectious Diseases (NFID) supports RSV education by engaging key audiences, sharing firsthand experiences of RSV among all age groups, and providing resources to help raise awareness of the burden of disease.
Improving Adult Vaccination Policy in Long-Term Care Settings. Technical Report.
With the World Immunization Week coming up, IFA has produced a study to deliver critical baseline data to help inform technical guidelines, as well as governmental and civil society dialogue and policy actions, to protect the health of LTC residents.